News

25 Jun 2025

Sequoia Economic Infrastructure Income shows resilience as NPLs fall and buybacks continue

Sequoia Economic Infrastructure Income (SEQI) has published its full-year results for the period ended 31 March 2025. While total net assets fell slightly to £1.44bn (from £1.52bn in 2024), the fund delivered a NAV total return of 6.1% over the year. This is modestly below its long-term target of 7–8%, but comes in a year […]

25 Jun 2025

Edinburgh Worldwide outperforms in volatile markets

Edinburgh Worldwide (EWI) has released interim results for the six months to 30 April 2025. The trust delivered a NAV total return of -2.9%, significantly ahead of the -7.2% fall in its benchmark, the S&P Global Small Cap Index. The share price declined by 1.9% as the discount to NAV narrowed from 7.6% to 6.7%. […]

25 Jun 2025
24 Jun 2025

Foresight Environmental Infrastructure delivers record portfolio cashflows and resets strategic focus

Foresight Environmental Infrastructure (FGEN) has reported its annual results for the year ended 31 March 2025, during which the company continued to generate robust income from its diversified portfolio despite a volatile macroeconomic environment for listed infrastructure trusts. For the tenth consecutive year, FGEN achieved record cash receipts from its underlying investments, totalling £90.4m, which […]

24 Jun 2025

Gresham House Energy Storage announces project-level equity deal for Glassenbury

Gresham House Energy Storage Fund (GRID) has completed an £8.6m third-party equity raise for Glassenbury Battery Storage Ltd, the special purpose vehicle which owns its Glassenbury A and B projects in Kent. The capital will fund the augmentation of the 50MW projects from 38MWh to 110MWh, increasing duration to 2.2 hours. The equity has been […]

24 Jun 2025

RTW Biotech Opportunities’ Corxel Pharmaceuticals makes clinical progress

RTW Biotech Opportunities (RTW) has provided an update on private portfolio company Corxel Pharmaceuticals, its second-largest core holding as at 31 May 2025, representing 8.3% of NAV. Corxel, a clinical-stage biopharma firm developing therapies for cardiometabolic diseases, recently announced two key developments relating to its lead candidate, CX11 – an investigational, once-daily oral GLP-1 receptor […]

24 Jun 2025

QuotedData’s morning briefing 24 June 2025 – CLDN, FJV, LTI, ESCT, CCJI, JEMA, SRE

In QuotedData’s morning briefing 24 June 2025, Caledonia is holding its public companies spotlight today, which includes a live webcast, Fidelity Japan shareholders have approved changes to its articles that will give the board six months rather than three to come up with proposals following its failed continuation vote, Mike Lindsell has been buying shares […]

23 Jun 2025

Ashoka WhiteOak Emerging Markets beats benchmark for second year

Ashoka WhiteOak Emerging Markets Trust (AWEM) has published its annual results for the year ended 31 March 2025, reporting a NAV total return of 8.8% for the period, 3.0 percentage points ahead of its benchmark, the MSCI Emerging Markets (GBP) Index. Since its IPO in May 2023, AWEM’s NAV is up 21.7% compared with a […]

23 Jun 2025

JPMorgan European Growth & Income reports another year of outperformance

JPMorgan European Growth & Income (JEGI) has reported another good year of performance, extending its track record of outperformance over its benchmark and peers to five consecutive years. For the year ended 31 March 2025, the trust delivered a NAV total return of 3.5%, ahead of the benchmark return of 2.5% and well above the […]

23 Jun 2025

SEIT posts steady NAV and reviews strategic options amid ongoing discount

SDCL Efficiency Income Trust (SEIT) has reported a total return on NAV of 7.1% and maintained its NAV per share at 90.6p for the year ended 31 March 2025. Dividends totalling 6.32p per share were declared and covered by portfolio cash inflows. However, with the shares continuing to trade at a deep discount to NAV, […]